← Open Payments lookup

DYLAN BOYD: Open Payments

NPI 1891357588 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,054 in 212 payments from 28 companies in 2025. Trend: 2023 $3,507 · 2024 $3,584 · 2025 $4,054

Food & beverage: $4,011Education: $43
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP36$853
Viatris Specialty LLC32$454
GlaxoSmithKline, LLC.28$390
Grifols USA, LLC13$314
GENZYME CORPORATION11$270
JAZZ PHARMACEUTICALS INC.10$228
Verona Pharma, Inc.13$221
Regeneron Healthcare Solutions, Inc.9$219
Boehringer Ingelheim Pharmaceuticals, Inc.12$208
ANI Pharmaceuticals, Inc.6$140

Products named: DUPIXENT, YUPELRI, TEZSPIRE, Prolastin-C Liquid, TRELEGY ELLIPTA, XYWAV, Ohtuvayre, FASENRA.

Industry payments across MS — which companies pay providers there.